8-K Announcements
6Material company update
May 13, 2026·SEC
Material company update
Apr 17, 2026·SEC
Material company update
Feb 5, 2026·SEC
Doximity, Inc.(DOCS)Earnings, Financials & Key Ratios
DOCS•NYSE
20.4× P/E·Price updated Jun 13, 2026
SectorHealthcareIndustryHealthcare ITSub-IndustryHealthcare Communications, Workforce and Supply Chain
AboutDoximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.Show more
- Revenue$645M+13.1%
- EBITDA$215M-9.9%
- Net Income$196M-12.2%
- EPS (Diluted)0.98-11.7%
- Gross Margin89.09%-1.2%
- EBITDA Margin33.33%-20.3%
- Operating Margin33.33%-16.5%
- Net Margin30.4%-22.3%
- ROE19.28%-14.3%
- ROIC19.81%-1.2%
- Debt/Equity0.01-6.4%
DOCS Key Insights
Doximity, Inc. (DOCS) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong 5Y profit CAGR of 31.3%
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 25.5%
- ✓Good 3Y average ROE of 19.2%
- ✓Healthy 5Y average net margin of 34.5%
✗Weaknesses
- ✗Weak momentum: RS Rating 11 (bottom 11%)
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when DOCS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
DOCS Price & Volume
Doximity, Inc. (DOCS) stock price & volume — 10-year historical chart
Loading chart...
DOCS Growth Metrics
Doximity, Inc. (DOCS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years25.53%
3 Years15.45%
TTM13.05%
Profit CAGR
10 Years-
5 Years31.32%
3 Years20.23%
TTM-12.16%
EPS CAGR
10 Years-
5 Years52.2%
3 Years22.74%
TTM-10.81%
Return on Capital
10 Years23.62%
5 Years19.08%
3 Years20.01%
Last Year20.7%
DOCS Recent Earnings
Doximity, Inc. (DOCS) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 11/12 qtrs (92%)
Q2 2026Latest
May 13, 2026EPS
$0.26
Est $0.28
-7.1%
Revenue
$145M
Est $144M
+0.9%
Q1 2026
Feb 5, 2026EPS
$0.46
Est $0.44
+4.5%
Revenue
$185M
Est $182M
+1.9%
Q4 2025
Nov 6, 2025EPS
$0.45
Est $0.38
+18.8%
Revenue
$169M
Est $158M
+6.7%
Q3 2025
Aug 7, 2025EPS
$0.36
Est $0.30
+19.4%
Revenue
$146M
Est $140M
+4.6%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 13, 2026 | $0.26vs $0.28-7.1% | $145Mvs $144M+0.9% |
| Q1 2026 | Feb 5, 2026 | $0.46vs $0.44+4.5% | $185Mvs $182M+1.9% |
| Q4 2025 | Nov 6, 2025 | $0.45vs $0.38+18.8% | $169Mvs $158M+6.7% |
| Q3 2025 | Aug 7, 2025 | $0.36vs $0.30+19.4% | $146Mvs $140M+4.6% |
Based on last 12 quarters of dataView full earnings history →
DOCS Peer Comparison
Doximity, Inc. (DOCS) competitors in Healthcare Communications, Workforce and Supply Chain — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HIMS | 5.89B | 26.82 | 52.59 | 59% | -0.56% | -2.48% | 2.34 | |
 WELL | 150.09B | 214.23 | 154.12 | 35.82% | 12.31% | 3.49% | 0.49 | |
 NVCR | 2.02B | 17.78 | -14.57 | 8.28% | -25.66% | -50.82% | 0.85 | |
 VEEV | 25.92B | 159.54 | 29.33 | 16.34% | 28.37% | 13.36% | 0.01 | |
 INVA | 1.68B | 22.74 | 6.89 | 18.52% | 118.91% | 47.59% | 0.23 | |
 PGNY | 2.09B | 26.63 | 40.97 | 10.4% | 5.23% | 13.34% | 0.05 | |
 TDOC | 1.32B | 7.34 | -6.44 | -1.54% | -6.81% | -12.37% | 0.75 | |
 AMWL | 152.21M | 9.11 | -1.53 | -1.98% | -48.16% | -33.48% | 0.02 |
Compare DOCS vs Peers
Doximity, Inc. (DOCS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
DOCS Income Statement
Doximity, Inc. (DOCS) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 85.69M | 116.39M | 206.9M | 343.55M | 419.05M | 475.42M | 570.4M | 644.86M |
Revenue Growth % | - | 35.82% | 77.76% | 66.05% | 21.98% | 13.45% | 19.98% | 13.05% |
Cost of Goods Sold | 10.89M | 14.9M | 31.2M | 39.79M | 53.49M | 50.67M | 55.87M | 70.33M |
COGS % of Revenue | 12.71% | 12.8% | 15.08% | 11.58% | 12.76% | 10.66% | 9.8% | 10.91% |
Gross Profit | 74.81M▲ 0% | 101.49M▲ 35.7% | 175.7M▲ 73.1% | 303.76M▲ 72.9% | 365.56M▲ 20.3% | 424.75M▲ 16.2% | 514.52M▲ 21.1% | 574.54M▲ 11.7% |
Gross Margin % | 87.29% | 87.2% | 84.92% | 88.42% | 87.24% | 89.34% | 90.2% | 89.09% |
Gross Profit Growth % | - | 35.67% | 73.12% | 72.89% | 20.35% | 16.19% | 21.14% | 11.66% |
Operating Expenses | 67.89M | 79.33M | 122.4M | 190.22M | 240.45M | 260.88M | 286.73M | 359.62M |
OpEx % of Revenue | 79.22% | 68.16% | 59.16% | 55.37% | 57.38% | 54.87% | 50.27% | 55.77% |
Selling, General & Admin | 40.39M | 46.89M | 78.53M | 127.88M | 160.27M | 170.96M | 191.38M | 228.91M |
SG&A % of Revenue | 47.13% | 40.29% | 37.95% | 37.22% | 38.25% | 35.96% | 33.55% | 35.5% |
Research & Development | 27.5M | 32.44M | 43.87M | 62.35M | 80.19M | 81.98M | 93.04M | 130.7M |
R&D % of Revenue | 32.09% | 27.87% | 21.21% | 18.15% | 19.14% | 17.24% | 16.31% | 20.27% |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 7.94M | 2.3M | 0 |
Operating Income | 6.92M▲ 0% | 22.16M▲ 220.2% | 53.3M▲ 140.5% | 113.54M▲ 113.0% | 125.11M▲ 10.2% | 163.88M▲ 31.0% | 227.8M▲ 39.0% | 214.92M▼ 5.7% |
Operating Margin % | 8.08% | 19.04% | 25.76% | 33.05% | 29.85% | 34.47% | 39.94% | 33.33% |
Operating Income Growth % | - | 220.23% | 140.5% | 113% | 10.19% | 30.99% | 39.01% | -5.65% |
EBITDA | 7.47M | 23.06M | 57.01M | 118.58M | 135.39M | 174.14M | 238.46M | 214.92M |
EBITDA Margin % | 8.72% | 19.82% | 27.55% | 34.52% | 32.31% | 36.63% | 41.81% | 33.33% |
EBITDA Growth % | - | 208.66% | 147.17% | 108.01% | 14.18% | 28.62% | 36.93% | -9.87% |
D&A (Non-Cash Add-back) | 551K | 900K | 3.7M | 5.04M | 10.28M | 10.27M | 10.66M | 0 |
EBIT | 6.92M | 22.16M | 53.3M | 113.54M | 125.11M | 171.81M | 230.1M | 214.92M |
Net Interest Income | 1.07M | 1.46M | 301K | 2.15M | 9.29M | 21.66M | 35.85M | 0 |
Interest Income | 1.07M | 1.46M | 301K | 2.15M | 9.29M | 21.66M | 35.85M | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Income/Expense | 1.01M | 1.35M | 4.47M | 469K | 8.05M | 21.32M | 35.77M | 35.09M |
Pretax Income | 7.93M▲ 0% | 23.51M▲ 196.5% | 57.77M▲ 145.7% | 114M▲ 97.3% | 133.16M▲ 16.8% | 185.2M▲ 39.1% | 263.57M▲ 42.3% | 250M▼ 5.1% |
Pretax Margin % | 9.25% | 20.2% | 27.92% | 33.18% | 31.78% | 38.96% | 46.21% | 38.77% |
Income Tax | 98K | -6.22M | 7.56M | -40.78M | 20.34M | 37.62M | 40.39M | 53.95M |
Effective Tax Rate % | 1.24% | -26.47% | 13.08% | -35.77% | 15.27% | 20.31% | 15.32% | 21.58% |
Net Income | 7.83M▲ 0% | 29.74M▲ 279.6% | 50.21M▲ 68.8% | 154.78M▲ 208.3% | 112.82M▼ 27.1% | 147.58M▲ 30.8% | 223.19M▲ 51.2% | 196.05M▼ 12.2% |
Net Margin % | 9.14% | 25.55% | 24.27% | 45.05% | 26.92% | 31.04% | 39.13% | 30.4% |
Net Income Growth % | - | 279.64% | 68.85% | 208.27% | -27.11% | 30.81% | 51.23% | -12.16% |
Net Income (Continuing) | 7.83M | 29.74M | 50.21M | 154.78M | 112.82M | 147.58M | 223.19M | 196.05M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 0.00▲ 0% | 0.06▲ 1706.1% | 0.12▲ 101.3% | 0.70▲ 483.3% | 0.53▼ 24.3% | 0.72▲ 35.8% | 1.11▲ 54.2% | 0.98▼ 11.7% |
EPS Growth % | - | - | 101.34% | 483.33% | -24.29% | 35.85% | 54.17% | -11.71% |
EPS (Basic) | 0.00 | 0.06 | 0.12 | 0.81 | 0.58 | 0.78 | 1.19 | 1.05 |
Diluted Shares Outstanding | 181.7M | 181.7M | 178.21M | 191.02M | 213.43M | 205.73M | 201.21M | 199.05M |
Basic Shares Outstanding | 181.7M | 181.7M | 178.21M | 163.48M | 193.18M | 190.17M | 186.84M | 187.01M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - |
DOCS Balance Sheet
Doximity, Inc. (DOCS) balance sheet — assets, liabilities & shareholders' equity
| Metric | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|
Total Current Assets | 83.36M | 122.97M | 209.4M | 904.14M | 975.45M | 912.94M | 1.09B | 944.26M |
Cash & Short-Term Investments | 62.33M | 86.45M | 142.53M | 798.11M | 841M | 762.9M | 915.66M | 748.6M |
Cash Only | 33.61M | 48.43M | 66.39M | 112.81M | 158.03M | 96.78M | 209.61M | 219.18M |
Short-Term Investments | 28.73M | 38.02M | 76.14M | 685.3M | 682.97M | 666.12M | 706.05M | 529.42M |
Accounts Receivable | 15.29M | 26.16M | 50.32M | 81.07M | 107.05M | 101.33M | 128.35M | 144.78M |
Days Sales Outstanding | 65.11 | 82.05 | 88.77 | 86.14 | 93.24 | 77.8 | 82.13 | 81.95 |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | - | - | - | - | - |
Other Current Assets | 2.97M | 3.41M | 5.86M | 5.51M | 27.41M | 48.71M | 44.6M | 50.88M |
Total Non-Current Assets | 3.21M | 15.95M | 42.32M | 87.22M | 161.44M | 166.43M | 175.69M | 179.42M |
Property, Plant & Equipment | 1.37M | 7.11M | 8.94M | 9.57M | 25.1M | 24.65M | 22.54M | 25.22M |
Fixed Asset Turnover | 62.60x | 16.37x | 23.15x | 35.88x | 16.70x | 19.29x | 25.30x | 25.57x |
Goodwill | 0 | 0 | 18.91M | 18.91M | 67.94M | 67.94M | 67.94M | 84.97M |
Intangible Assets | 407K | 393K | 9.6M | 7.91M | 31.84M | 27.32M | 23.07M | 35.33M |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 1.43M | 1.35M | 2.76M | 2.26M | 1.65M | 1.46M | 2.12M | 1.92M |
Total Assets | 86.56M▲ 0% | 138.92M▲ 60.5% | 251.72M▲ 81.2% | 991.36M▲ 293.8% | 1.14B▲ 14.7% | 1.08B▼ 5.1% | 1.26B▲ 17.1% | 1.12B▼ 11.1% |
Asset Turnover | 0.99x | 0.84x | 0.82x | 0.35x | 0.37x | 0.44x | 0.45x | 0.57x |
Asset Growth % | - | 60.49% | 81.2% | 293.83% | 14.68% | -5.06% | 17.13% | -11.12% |
Total Current Liabilities | 37.81M | 55.71M | 102.04M | 111.28M | 139.51M | 147.25M | 156.26M | 154.97M |
Accounts Payable | 938K | 1.42M | 1.51M | 463K | 1.27M | 2.25M | 1.36M | 4.01M |
Days Payables Outstanding | 31.44 | 34.71 | 17.73 | 4.25 | 8.68 | 16.23 | 8.86 | 20.81 |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.11M |
Deferred Revenue (Current) | 0 | 44.3M | 83.27M | 84.91M | 105.24M | 99.14M | 114.28M | 106.05M |
Other Current Liabilities | 32.49M | 283K | 3.55M | 4.88M | 11.92M | 14.77M | 12.06M | 42.8M |
Current Ratio | 2.20x | 2.21x | 2.05x | 8.12x | 6.99x | 6.20x | 6.97x | 6.09x |
Quick Ratio | 2.20x | 2.21x | 2.05x | 8.12x | 6.99x | 6.20x | 6.97x | 6.09x |
Cash Conversion Cycle | - | - | - | - | - | - | - | - |
Total Non-Current Liabilities | 0 | 82.07M | 82.93M | 1.48M | 31.27M | 30.73M | 25.43M | 17.88M |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Capital Lease Obligations | 0 | 324K | 284K | 447K | 13.88M | 12.4M | 10.19M | 8.07M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 81.46M | 82.43M | 956K | 17.18M | 18.12M | 14.96M | 9.4M |
Total Liabilities | 37.81M | 137.78M | 184.98M | 112.76M | 170.77M | 177.98M | 181.68M | 172.85M |
Total Debt | 0 | 2.28M | 1.25M | 1.09M | 15.64M | 14.55M | 12.4M | 10.19M |
Net Debt | -33.61M | -46.15M | -65.14M | -111.72M | -142.39M | -82.24M | -197.22M | -208.99M |
Debt / Equity | - | 2.01x | 0.02x | 0.00x | 0.02x | 0.02x | 0.01x | 0.01x |
Debt / EBITDA | - | 0.10x | 0.02x | 0.01x | 0.12x | 0.08x | 0.05x | 0.05x |
Net Debt / EBITDA | -4.50x | -2.00x | -1.14x | -0.94x | -1.05x | -0.47x | -0.83x | -0.97x |
Interest Coverage | - | - | - | - | - | - | - | - |
Total Equity | 48.5M▲ 0% | 1.14M▼ 97.7% | 66.74M▲ 5775.3% | 878.59M▲ 1216.4% | 966.12M▲ 10.0% | 901.4M▼ 6.7% | 1.08B▲ 20.1% | 950.84M▼ 12.2% |
Equity Growth % | - | -97.66% | 5775.26% | 1216.38% | 9.96% | -6.7% | 20.11% | -12.17% |
Book Value per Share | 0.27 | 0.01 | 0.37 | 4.60 | 4.53 | 4.38 | 5.38 | 4.78 |
Total Shareholders' Equity | 48.5M | 1.14M | 66.74M | 878.59M | 966.12M | 901.4M | 1.08B | 950.84M |
Common Stock | 33K | 68K | 83K | 192K | 194K | 187K | 189K | 183K |
Retained Earnings | -43.62M | -13.89M | 36.32M | 191.11M | 217.85M | 79.99M | 186.89M | -51.06M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 0 | 0 | -21K | -15.29M | -14.08M | -2.66M | 1.32M | 28K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DOCS Cash Flow Statement
Doximity, Inc. (DOCS) cash flow — operating, investing & free cash flow history
| Metric | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|
Cash from Operations | 15.31M | 26.2M | 82.97M | 126.58M | 179.6M | 184.1M | 273.26M | 326.46M |
Operating CF Margin % | 17.86% | 22.51% | 40.1% | 36.84% | 42.86% | 38.72% | 47.91% | 50.62% |
Operating CF Growth % | - | 71.17% | 216.7% | 52.55% | 41.89% | 2.5% | 48.44% | 19.47% |
Net Income | 7.83M | 29.74M | 50.21M | 154.78M | 112.82M | 147.58M | 223.19M | 196.05M |
Depreciation & Amortization | 551K | 900K | 10.59M | 5.04M | 10.28M | 10.27M | 10.66M | 14.38M |
Stock-Based Compensation | 2.34M | 2.35M | 7.25M | 31.44M | 47.83M | 51.08M | 72.39M | 0 |
Deferred Taxes | 480K | -7.1M | 4.99M | -41.25M | 13.23M | -8.59M | -11.59M | 32.14M |
Other Non-Cash Items | 5.2M | 6.58M | -95K | 16.89M | 16.47M | 8.29M | 2.72M | 129.59M |
Working Capital Changes | -1.1M | -6.27M | 10.03M | -40.33M | -21.03M | -24.52M | -24.1M | -45.7M |
Change in Receivables | 2.53M | -12.04M | -20.45M | -31.02M | -26.24M | 3.99M | -27.21M | -16.88M |
Change in Inventory | -4.07M | -6.93M | 1.21M | 0 | 0 | 0 | 0 | 0 |
Change in Payables | 726K | 5.06M | -243K | 8.66M | -195K | 8.33M | -663K | 4.27M |
Cash from Investing | -9.07M | -13.1M | -70.42M | -640.57M | -59.92M | 31.19M | -29.3M | 147.17M |
Capital Expenditures | -1.19M | -4.24M | -4.61M | -5.7M | -6.18M | -147K | -6.53M | -8.96M |
CapEx % of Revenue | 1.39% | 3.65% | 2.23% | 1.66% | 1.48% | 0.03% | 1.14% | 1.39% |
Acquisitions | 1.08M | 3.96M | -27.45M | 0 | -53.5M | 0 | 0 | -26.53M |
Investments | - | - | - | - | - | - | - | - |
Other Investing | -1.08M | -3.96M | -12K | 595K | 0 | -5.65M | 0 | 0 |
Cash from Financing | 985K | 1.72M | 5.41M | 560.41M | -74.46M | -276.52M | -131.14M | -464.06M |
Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Equity Issued (Net) | 0 | 0 | -2.02M | 551.21M | -85.32M | -280.72M | -96.99M | -417.98M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | -2.02M | -2.7M | -85.32M | -280.72M | -120.29M | -431.65M |
Other Financing | 985K | 1.72M | 7.43M | 9.21M | 10.86M | 4.19M | -34.15M | -46.09M |
Net Change in Cash | 7.22M▲ 0% | 14.82M▲ 105.2% | 17.96M▲ 21.2% | 46.42M▲ 158.4% | 45.22M▼ 2.6% | -61.24M▼ 235.4% | 112.83M▲ 284.2% | 9.56M▼ 91.5% |
Free Cash Flow | 14.12M▲ 0% | 21.95M▲ 55.5% | 78.36M▲ 256.9% | 120.88M▲ 54.3% | 173.42M▲ 43.5% | 178.29M▲ 2.8% | 266.74M▲ 49.6% | 0▼ 100.0% |
FCF Margin % | 16.47% | 18.86% | 37.88% | 35.19% | 41.38% | 37.5% | 46.76% | - |
FCF Growth % | - | 55.53% | 256.93% | 54.25% | 43.47% | 2.81% | 49.61% | -100% |
FCF per Share | 0.08 | 0.12 | 0.44 | 0.63 | 0.81 | 0.87 | 1.33 | - |
FCF Conversion (FCF/Net Income) | 1.95x | 0.88x | 1.65x | 0.82x | 1.59x | 1.25x | 1.22x | 1.67x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 4K | 1.24M | 5.97M | 206K | 5.23M | 51.27M | 55.65M | 0 |
DOCS Key Ratios
Doximity, Inc. (DOCS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 16.15% | 119.83% | 147.94% | 32.75% | 12.23% | 15.81% | 22.5% | 19.28% |
| Return on Invested Capital (ROIC) | 34.86% | - | 2492.35% | 22.16% | 11.8% | 14.96% | 20.05% | 19.81% |
| Gross Margin | 87.29% | 87.2% | 84.92% | 88.42% | 87.24% | 89.34% | 90.2% | 89.09% |
| Net Margin | 9.14% | 25.55% | 24.27% | 45.05% | 26.92% | 31.04% | 39.13% | 30.4% |
| Debt / Equity | - | 2.01x | 0.02x | 0.00x | 0.02x | 0.02x | 0.01x | 0.01x |
| FCF Conversion | 1.95x | 0.88x | 1.65x | 0.82x | 1.59x | 1.25x | 1.22x | 1.67x |
| Revenue Growth | - | 35.82% | 77.76% | 66.05% | 21.98% | 13.45% | 19.98% | 13.05% |
Related:DOCS Dividend History·DOCS Revenue History·DOCS Price History·DOCS P/E History·DOCS Financial Ratios·DOCS Institutional Holders
DOCS SEC Filings & Documents
Doximity, Inc. (DOCS) SEC filings — annual & quarterly reports (10-K, 10-Q)
DOCS Frequently Asked Questions
Doximity, Inc. (DOCS) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Doximity, Inc. (DOCS) reported $644.9M in revenue for fiscal year 2026. This represents a 653% increase from $85.7M in 2019.
Doximity, Inc. (DOCS) grew revenue by 13.1% over the past year. This is steady growth.
Yes, Doximity, Inc. (DOCS) is profitable, generating $196.1M in net income for fiscal year 2026 (30.4% net margin).
Dividend & Returns
Doximity, Inc. (DOCS) has a return on equity (ROE) of 19.3%. This is reasonable for most industries.
Doximity, Inc. (DOCS) generated $214.6M in free cash flow for fiscal year 2026. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.